Contribution: Industrial Research Assistance Program – Contributions to Firms
Fusion Pharmaceuticals Inc.
$75,000.00
Investigating the synergies of targeted radiotherapy and immunotherapy for treating cancer
FY 2018-19 · 2018-10-01
Summary
Fusion Pharmaceuticals, Inc. is a new Canadian pharmaceutical company that develops innovative targeted radiotherapy drugs. The project is focused on studying the synergistic effects of Fusion’s targeted radiotherapies with immunotherapies to create new cancer treatment strategies and expand investment and commercialization opportunities for Fusion.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Hamilton|Hamilton, Ontario, Canada
Recipient Type
For-profit organization
Business Number
823021795
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 75,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 75 000 dollars.
Agreement End Date
2019-09-30
Agreement Number
914681
Agreement Start Date
2018-10-01
Agreement Title
Investigating the synergies of targeted radiotherapy and immunotherapy for treating cancer
Agreement Title (French)
Étudier les synergies entre la radiothérapie et l'immunothérapie ciblées pour traiter le cancer
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2019-03-05
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Fusion Pharmaceuticals, Inc. is a new Canadian pharmaceutical company that develops innovative targeted radiotherapy drugs. The project is focused on studying the synergistic effects of Fusion’s targeted radiotherapies with immunotherapies to create new cancer treatment strategies and expand investment and commercialization opportunities for Fusion.
Description (French)
Fusion Pharmaceuticals, Inc. est une nouvelle entreprise pharmaceutique canadienne, qui développe des médicaments novateurs ciblés pour la radiothérapie. Le projet se concentre sur l’étude des effets synergiques des radiothérapies ciblées de Fusion avec les immunothérapies afin de créer de nouvelles stratégies de traitement du cancer et d’élargir les possibilités d’investissement et de commercialisation de Fusion.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Hamilton Centre
Federal Riding (French)
Hamilton-Centre
Federal Riding Number
35035
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
823021795
Recipient City
Hamilton|Hamilton
Recipient Country
CA
Recipient Legal Name
Fusion Pharmaceuticals Inc.
Recipient Postal Code
L8P 0A6
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q4-914681
